Net clinical benefit of rivaroxaban compared with warfarin in atrial fibrillation: Results from ROCKET AF

AS Barnett, DD Cyr, SG Goodman, BS Levitan… - International journal of …, 2018 - Elsevier
Aims The aim of this study was to determine the net clinical benefit (NCB) of rivaroxaban
compared with warfarin in patients with atrial fibrillation. Methods This was a retrospective …

Net clinical benefit of rivaroxaban compared with warfarin in atrial fibrillation: Results from ROCKET AF.

AS Barnett, DD Cyr, SG Goodman… - … Journal of Cardiology, 2018 - europepmc.org
AIMS: The aim of this study was to determine the net clinical benefit (NCB) of rivaroxaban
compared with warfarin in patients with atrial fibrillation. METHODS: This was a retrospective …

Net clinical benefit of rivaroxaban compared with warfarin in atrial fibrillation: Results from ROCKET AF

AS Barnett, DD Cyr… - International …, 2018 - research-repository.uwa.edu.au
Aims: The aim of this study was to determine the net clinical benefit (NCB) of rivaroxaban
compared with warfarin in patients with atrial fibrillation. Methods: This was a retrospective …

Net clinical benefit of rivaroxaban compared with warfarin in atrial fibrillation: Results from ROCKET AF

AS Barnett, DD Cyr… - International …, 2018 - internationaljournalofcardiology.com
Aims The aim of this study was to determine the net clinical benefit (NCB) of rivaroxaban
compared with warfarin in patients with atrial fibrillation. Methods This was a retrospective …

Net clinical benefit of rivaroxaban compared with warfarin in atrial fibrillation: Results from ROCKET AF

AS Barnett, DD Cyr, SG Goodman… - International Journal …, 2018 - research.ed.ac.uk
AIMS: The aim of this study was to determine the net clinical benefit (NCB) of rivaroxaban
compared with warfarin in patients with atrial fibrillation. METHODS: This was a retrospective …

Net clinical benefit of rivaroxaban compared with warfarin in atrial fibrillation: Results from ROCKET AF

AS Barnett, DD Cyr, SG Goodman, BS Levitan, Z Yuan… - 2018 - pubmed.ncbi.nlm.nih.gov
Aims The aim of this study was to determine the net clinical benefit (NCB) of rivaroxaban
compared with warfarin in patients with atrial fibrillation. Methods This was a retrospective …